NCT00134511
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Pfizer Investigational Site Boston, Massachusetts, United States
- Pfizer Investigational Site Chicoutimi, Quebec, Canada
- Pfizer Investigational Site Ste-Foy, Quebec, Canada
- Pfizer Investigational Site Parktown, Johannesburg, South Africa